Regencell Bioscience Holdings Limited

NasdaqCM:RGC

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🏥 Hospitals & Clinics

💊 Pharmaceuticals

💻 Telehealth

Location

Hong Kong

Market Cap

USD 9.55 B

Share Price

USD 17.40

Avg Daily Volume

3,111,760

Change (1 day)

-9.89%

Change (1 year)

400.00%

Change (YTD)

252.23%

Regencell Bioscience Holdings Limited Operating Cash Flow for the Trailing 12 Months (TTM) ending July 10, 2025: N/A

Regencell Bioscience Holdings Limited Operating Cash Flow is NA for the Trailing 12 Months (TTM) ending July 10, 2025. Operating cash flow is cash generated from the company’s regular business operations.

Competitors

AbbVie Inc.

USD 190.62

ABBV

+0.85 0.45%

Novo Nordisk A/S

USD 69.43

NOVO-B.CO

-1.17 -1.65%

Roche Holding AG

USD 347.13

RO.SW

+4.68 1.37%

Novartis AG

USD 122.69

NOVN.SW

+0.12 0.10%

Abbott Laboratories

USD 133.22

ABT

-0.14 -0.10%

AstraZeneca PLC

USD 140.76

AZN.L

+0.34 0.24%

Merck & Co., Inc.

USD 83.71

MRK

+2.34 2.88%

Amgen Inc.

USD 296.52

AMGN

-0.48 -0.16%

Pfizer Inc.

USD 25.56

PFE

-0.06 -0.23%

Gilead Sciences, Inc.

USD 113.24

GILD

+2.18 1.96%

Sanofi

USD 97.65

SAN.PA

-0.05 -0.05%

Vertex Pharmaceuticals Incorporated

USD 478.96

VRTX

+12.60 2.70%

Bristol-Myers Squibb Company

USD 47.66

BMY

+0.62 1.32%

GSK plc

USD 19.36

GSK.L

+0.16 0.81%

CSL Limited

USD 159.25

CSL.AX

-1.34 -0.84%

Chugai Pharmaceutical Co., Ltd.

USD 46.51

4519.T

-0.57 -1.20%

Regeneron Pharmaceuticals, Inc.

USD 552.58

REGN

+4.83 0.88%

MERCK Kommanditgesellschaft auf Aktien

USD 130.44

MRK.DE

-0.41 -0.31%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.96

600276.SS

+0.52 7.00%

Takeda Pharmaceutical Company Limited

USD 30.27

4502.T

+0.31 1.03%

Key Data

Date	Operating Cash Flow	Capital Expenditure	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities